Mometnum, Growth & Innovation: Portfolio Performance

17 de fev.

My portfolio is up by more than 11% in 2024, and up by more than 30% over the last 4 months. Here is a summary of our current stock holdings:

tradingview.com/watchlists/128292848/

1. NASDAQ: TQQQ (ProShares UltraPro QQQ)
Overview: TQQQ is a leveraged ETF designed to return three times the daily performance of the NASDAQ-100 Index. It's suitable for experienced traders due to its high volatility and potential for significant gains or losses within short periods.
Considerations: The performance of TQQQ closely follows the tech-heavy NASDAQ-100 index, making it sensitive to movements in technology stocks. Given its leveraged nature, it's important to monitor closely and consider it for short-term trades rather than long-term investments.

2. NYSE: CCJ (Cameco Corporation)
Overview: Cameco is one of the world's largest uranium producers. The company's performance is closely tied to the demand for nuclear energy and uranium prices.
Considerations: With growing interest in clean energy, nuclear power may see increased demand, potentially benefiting Cameco. However, the market for uranium can be volatile, influenced by regulatory changes and global energy policies.

3. NASDAQ:ROKU (Roku, Inc.)
Overview: Roku is a major player in the streaming media sector, offering devices and platforms that connect users to streaming content.
Considerations: Roku's performance is influenced by its ability to attract new users, its partnerships with content providers, and competition within the streaming industry. The shift towards streaming entertainment can benefit Roku, but it operates in a highly competitive market.

4. NASDAQ: MELI (MercadoLibre, Inc.)
Overview: Often referred to as the "Amazon of Latin America," MercadoLibre operates a marketplace, payments, and e-commerce platform in Latin America.
Considerations: MELI benefits from the growing e-commerce and digital payments sector in Latin America. Its performance is influenced by regional economic conditions, internet penetration rates, and competitive pressures.

5. NASDAQ: VRTX (Vertex Pharmaceuticals Incorporated)
Overview: Vertex Pharmaceuticals is a biotechnology company focusing on developing treatments for cystic fibrosis and other diseases.
Considerations: VRTX's performance is heavily dependent on its drug pipeline's success, regulatory approvals, and patent protections. The biotech sector is known for its high risk/reward ratio, with significant potential for both gains and losses.

6. NASDAQ: IONS (Ionis Pharmaceuticals, Inc.)
Overview: Ionis specializes in RNA-targeted drug discovery and development, focusing on a wide range of diseases.
Considerations: Like VRTX, IONS' success hinges on its research outcomes, clinical trial results, and regulatory environment. It's a high-risk investment with the potential for substantial rewards based on drug development success.

7. NASDAQ:AVDX (Avidity Biosciences, Inc.)
Overview: Assuming AVDX was intended to refer to a biotech company, it's important to verify the ticker symbol as it wasn't recognized. If it's a typo, the actual company might also be in a high-risk biotech or related sector.
Considerations: For biotech firms, investor focus should be on product pipelines, funding for research, and potential for regulatory approvals.

8. NYSE:GRMN (Garmin Ltd.)
Overview: Garmin is known for its GPS technology and wearable devices. The company has diversified its product line to include fitness, aviation, marine, and outdoor products.
Considerations: Garmin's performance is influenced by its innovation in technology, market penetration in its various segments, and competition with other tech and wearable companies.

9. NASDAQ:CASY (Casey's General Stores, Inc.)
Overview: Casey's operates convenience stores across the United States, offering a mix of food, groceries, and fuel.
Considerations: Casey's is impacted by fuel price fluctuations, consumer spending habits, and its ability to expand its store network. Its focus on community and local markets provides a niche advantage.